See also this year's filing and all EDGAR filings for this company.
PDF Report 0001659617_2024_Moleculin_Biotech_Inc.pdf
Logs
Graph
Absolute values for 0001659617, Moleculin Biotech Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 26,273,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 272,000 |
| 3 | remainder_Assets | 11,672,000 |
| 4 | LiabilitiesCurrent | 6,815,000 |
| 5 | LiabilitiesNoncurrent | 474,000 |
| 6 | remainder_Liabilities | 4,855,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,135,533 |
| 9 | ResearchAndDevelopmentExpense | 20,289,358 |
| 10 | remainder_Expenses | 1,037,248 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,004,654 |
| 13 | remainder_ComprehensiveNetIncome | -24,418 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 38,217,000 |
| 1 | Liabilities | 12,144,000 |
| 2 | Expenses | 30,462,139 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 26,073,000 |
| 5 | NetIncome | -29,457,485 |
| 6 | ComprehensiveNetIncome | -29,469,694 |
| 7 | BaseVar | 40,926,106 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.09 |
| 9 | EconomicCapitalRatio | 2.37 |
Edgar->Model Mapping
Feature Distribution
Change over Time
